News/ News/ R&D Neurocrine and Xenon agree $1.75bn epilepsy R&D tie-up Richard Staines epilepsy, Neurocrine, neurology, R&D, Xenon 0 Comment Two biotechs, Neurocrine Biosciences and Xenon, have announced a licence and collaboration agreement to develop first-in-class treatments for Share X Neurocrine and Xenon agree $1.75bn epilepsy R&D tie-up https://pharmaphorum.com/news/neurocrine-and-xenon-agree-1-75bn-epilepsy-rd-tie-up/
